Just months after betting up to $1.58 billion on the drug discovery and early development chops of IFM Therapeutics LLC, Novartis AG is again investing in the Boston-based company. This time, it has …
More Novartis options IFM Due, pledging up to $840M for cGAS/STING programs Videos